These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 34272700)
21. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors. Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369 [TBL] [Abstract][Full Text] [Related]
22. Structural and functional studies of UDP-glucuronosyltransferases. Radominska-Pandya A; Czernik PJ; Little JM; Battaglia E; Mackenzie PI Drug Metab Rev; 1999 Nov; 31(4):817-99. PubMed ID: 10575553 [TBL] [Abstract][Full Text] [Related]
23. Chemical modification of rat hepatic microsomes with N-ethylmaleimide results in inactivation of both UDP-N-acetylglucosamine-dependent stimulation of glucuronidation and UDP-glucuronic acid uptake. Ikushiro S; Emi Y; Kimura S; Iyanagi T Biochim Biophys Acta; 1999 Aug; 1428(2-3):388-96. PubMed ID: 10434058 [TBL] [Abstract][Full Text] [Related]
24. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver. Mano Y; Usui T; Kamimura H Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480 [TBL] [Abstract][Full Text] [Related]
25. Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family. Kobayashi T; Sleeman JE; Coughtrie MW; Burchell B Biochem J; 2006 Dec; 400(2):281-9. PubMed ID: 16965264 [TBL] [Abstract][Full Text] [Related]
26. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases. Narayanan R; LeDuc B; Williams DA Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263 [TBL] [Abstract][Full Text] [Related]
27. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution. Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9. Mahajan MK; Uttamsingh V; Gan LS; Leduc B; Williams DA J Pharm Sci; 2011 Feb; 100(2):784-93. PubMed ID: 20669329 [TBL] [Abstract][Full Text] [Related]
29. Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modeling: confirmation with biochemical evidence. Banerjee R; Pennington MW; Garza A; Owens IS Biochemistry; 2008 Jul; 47(28):7385-92. PubMed ID: 18570380 [TBL] [Abstract][Full Text] [Related]
30. Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6. Battaglia E; Terrier N; Mizeracka M; Senay C; Magdalou J; Fournel-Gigleux S; Radominska-Pandya A Drug Metab Dispos; 1998 Aug; 26(8):812-7. PubMed ID: 9698297 [TBL] [Abstract][Full Text] [Related]
31. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast. Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030 [TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin. Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546 [TBL] [Abstract][Full Text] [Related]
33. A functional role for histidyl residues of the UDP-glucuronic acid carrier in rat liver endoplasmic reticulum membranes. Battaglia E; Radominska-Pandya A Biochemistry; 1998 Jan; 37(1):258-63. PubMed ID: 9425046 [TBL] [Abstract][Full Text] [Related]
34. Characterisation of UDP-glucuronosyltransferase activity in sea turtle Dias VHV; Mattos JJ; Bastolla CLV; Lüchmann KH; Bainy ACD Xenobiotica; 2022 Dec; 52(12):1011-1019. PubMed ID: 36594659 [TBL] [Abstract][Full Text] [Related]
35. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite. Katoh M; Matsui T; Yokoi T Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234 [TBL] [Abstract][Full Text] [Related]
36. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment. Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128 [TBL] [Abstract][Full Text] [Related]
37. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Williams JA; Hyland R; Jones BC; Smith DA; Hurst S; Goosen TC; Peterkin V; Koup JR; Ball SE Drug Metab Dispos; 2004 Nov; 32(11):1201-8. PubMed ID: 15304429 [TBL] [Abstract][Full Text] [Related]
38. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity. Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573 [TBL] [Abstract][Full Text] [Related]
39. Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates. Wang M; Lu J; Li J; Qi H; Wang Y; Zhang H Food Chem Toxicol; 2014 Feb; 64():135-43. PubMed ID: 24296138 [TBL] [Abstract][Full Text] [Related]
40. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Watanabe Y; Nakajima M; Yokoi T Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]